InvestSMART

BCAL Diagnostics Limited (ASX: BDX) - Announcements

Current share price for BDX : $0.081 0.004 (4.71%)+

ASX company news and announcements for BCAL Diagnostics Limited (BDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All BCAL Diagnostics Limited (BDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than BCAL Diagnostics Limited (BDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for BCAL Diagnostics Limited (BDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$30 Collaboration with KIMS & Indo-American Hospitals Hyderabad 29 Nov 2023 9:29AM $0.100 $0.081 fallen by 19%
$30 Director Change of Interest Notices X 4 28 Nov 2023 11:53AM $0.100 $0.081 fallen by 19%
$30 Change in substantial holding 28 Nov 2023 11:16AM $0.100 $0.081 fallen by 19%
$30 Cleansing Notice 27 Nov 2023 12:42PM $0.100 $0.081 fallen by 19%
$30 Application for quotation of securities - BDX 27 Nov 2023 12:37PM $0.100 $0.081 fallen by 19%
$30 Application for quotation of securities - BDX 27 Nov 2023 8:12AM $0.100 $0.081 fallen by 19%
$30 Application for quotation of securities - BDX 24 Nov 2023 8:20AM $0.110 $0.081 fallen by 26.36%
$30 Results of Meeting 22 Nov 2023 12:50PM $0.105 $0.081 fallen by 22.86%
$30 Annual General Meeting Presentation 22 Nov 2023 10:28AM $0.110 $0.081 fallen by 26.36%
$30 BCAL Receives Research and Development Tax Offset $3m 14 Nov 2023 9:33AM $0.105 $0.081 fallen by 22.86%
$30 BCAL Files Further Foundational Patent Application 6 Nov 2023 8:21AM $0.100 $0.081 fallen by 19%
$30 Quarterly Activities/Appendix 4C Cash Flow Report 31 Oct 2023 12:24PM $0.105 $0.081 fallen by 22.86%
$30 Letter to Shareholders re Annual General Meeting Notice 20 Oct 2023 8:23AM $0.097 $0.081 fallen by 16.49%
$30 Notice of Annual General Meeting/Proxy Form 20 Oct 2023 8:23AM $0.097 $0.081 fallen by 16.49%
$30 Notification regarding unquoted securities - BDX 17 Oct 2023 6:21PM $0.097 $0.081 fallen by 16.49%
$30 Cleansing Notice 17 Oct 2023 6:10PM $0.097 $0.081 fallen by 16.49%
$30 Application for quotation of securities - BDX 17 Oct 2023 5:45PM $0.097 $0.081 fallen by 16.49%
$30 AGM Date and Closing Date for Director Nominations 4 Oct 2023 8:25PM $0.100 $0.081 fallen by 19%
$30 Annual Report to shareholders 29 Sep 2023 1:05PM $0.105 $0.081 fallen by 22.86%
$30 Appendix 4G & Corporate Governance Statement 29 Sep 2023 12:59PM $0.105 $0.081 fallen by 22.86%
$30 Directors Change of Interest Notice X 5 22 Sep 2023 8:18AM $0.120 $0.081 fallen by 32.50%
$30 Cleansing Notice 19 Sep 2023 8:20AM $0.115 $0.081 fallen by 29.57%
$30 Application for quotation of securities - BDX 18 Sep 2023 6:45PM $0.115 $0.081 fallen by 29.57%
$30 Application for quotation of securities - BDX 18 Sep 2023 6:42PM $0.115 $0.081 fallen by 29.57%
$30 BCAL Share Purchase Plan Closes 18 Sep 2023 11:05AM $0.120 $0.081 fallen by 32.50%

151 - 175 of 274 results

Page 7 of 11

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.